Pyrosequencing™-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance

Author： Rohrbacher Maren   Kirchhof Anja   Geisslinger Gerd   Lötsch Jörn  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.7, 2006-10, pp. : 995-1002

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Letter to the Editor: Pyrosequencing™™-based screening for the genetic polymorphism CYP2B6 1459 C>T

By Doehring Alexandra   Löötsch Jöörn  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1577-1579

Future Medicine

Access to resources Recommend Favorite

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia   Roots Ivar   Goldammer Mark   Rosenkranz Bernd  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance

By Xu Meijuan   Ju Wenzheng   Hao Haiping   Wang Guangji   Li Ping  

Drug Metabolism Reviews, Vol. 45, Iss. 3, 2013-08 ,pp. : 311-352

Informa Healthcare

Access to resources Recommend Favorite

Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

By Desta Z.   Zhao X.   Shin J-G.   Flockhart D.A.  

Clinical Pharmacokinetics, Vol. 41, Iss. 12, 2002-01 ,pp. : 913-958

Adis International

Access to resources Recommend Favorite

Pyrosequencing™™ of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance

By Skarke Carsten   Schuss Patrick   Kirchhof Anja   Doehring Alexandra   Geißßlinger Gerd   Löötsch Jöörn  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1643-1660

Future Medicine

Access to resources Recommend Favorite